Metalyse (tenecteplase) 8000 units (40 mg) and 10000 units (50 mg) powder and solvent for solution for injection: temporary supply shortage
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Metalyse
|
| Active substance |
tenecteplase
|
| Therapeutic area (MeSH) |
Myocardial Infarction
|
| Procedure number |
EMEA/H/C/000306
|
| Regulatory outcome |
Maintenance
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
B01AD11
|
| Dissemination date |
23/09/2022
|